Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Wilson Therapeutics

Request full access

Developing novel treatments for Wilson Disease

Stockholm, SwedenFounded 1984Biotech & Life Sciences

About Wilson Therapeutics

Wilson Therapeutics, now part of Alexion Pharmaceuticals, is a biopharmaceutical company dedicated to developing transformative therapies for individuals suffering from rare and severe diseases. The company primarily serves patients with limited treatment options, focusing on conditions that are often overlooked by larger pharmaceutical firms. Operating within the niche market of rare diseases, Wilson Therapeutics employs a business model centered around research and development, clinical trials, and strategic partnerships. Revenue is generated through the commercialization of its proprietary therapies, often in collaboration with third-party companies in select countries to manage local commercial operations. By addressing unmet medical needs, Wilson Therapeutics aims to create significant value for patients and their families, ultimately improving their quality of life.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1984
Headquarters
Stockholm, Sweden
Listing
IPO 2016
Employees
702
Open positions
None listed
Dealroom signal
83.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Neurology, Biotech and Pharma
Business model
Manufacturing
Client focus
B2B, B2C

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Apr 2018 $855M $855M Alexion Pharmaceuticals —
POST IPO EQUITY✓Other financing Dec 2017 $30M — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMargin
2026 $723M 0% $701M 96.9% $710M 98.1%
2025 $723M 0% $701M 96.9% $710M 98.1%
2024 $723M 0% $701M 96.9% $710M 98.1%
2023 $723M 0% $701M 96.9%
2022 $723M 0% $701M 96.9%
2021 $723M 0% $701M 96.9%
2020 $723M — $701M 96.9%
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Wilson Therapeutics website traffic

Latest recorded traffic for Wilson Therapeutics is 0 monthly website visits. Wilson Therapeutics's team grew 83.3% over the past year.

Latest monthly visits0 1-year team growth+83.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Wilson Therapeutics in the Stockholm ecosystem

Live from Dealroom

The Wilson Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Abingworth
  • MVM Life Science Partners
  • NeoMed
  • HealthCap

Other known investors1 additional known investor

  • Alexion Pharmaceuticals
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇵🇰 Pakistan97.6%
🇦🇪 United Arab Emirates1.4%
🇨🇦 Canada0.3%
🇶🇦 Qatar0.3%
🇸🇦 Saudi Arabia0.3%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Wilson Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Wilson Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.